Resource Center

Aug 9, 2016
  |  Video

Improving Bioavailability During Lead Optimization Using Global Sensitivity Analysis of Physiologically-Based Pharmacokinetics Modeling

In this presentation, Dr. Eric Martin of Novartis discusses improving bioavailability during lead optimization using global sensitivity analysis (GSA) of physiologically based pharmacokinetics in GastroPlus.

By Pankaj R Daga, Michael B Bolger, Robert D Clark

Contact Us About This Video